Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

CLARIVATE PLC

(CLVT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Clarivate : Measures Research Performance of the World's Leading Economies in Annual G20 Scorecard Report

10/19/2021 | 03:01am EST

Web of Science data uncovers links between G20 nations' response to COVID-19 and research subject diversity

LONDON, Oct. 19, 2021 /CNW/ -- Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today launched a new report which examines the research performance of each of the member countries of the G20 with a visual comparative snapshot for each nation. It also includes a special analysis of the G20 members' COVID-19 research as indexed in the Web of Science™ research publication and citation index.

The report, The Annual G20 Scorecard – Research Performance 2021 has been created by the Institute for Scientific Information™ at Clarivate ahead of this year's G20 Summit, which will be hosted virtually by Rome, Italy on October 30-31. It includes both a written summary and an array of graphs and exhibits that highlight the research performance of Argentina, Australia, Brazil, Canada, Mainland China, France, Germany, India, Indonesia, Italy, Japan, Mexico, Russia, Saudi Arabia, South Africa, South Korea, Turkey, the United Kingdom and the United States.

The report focuses on the different national responses to COVID-19 and the link to each region's research investment and subject diversity. It finds that regions with more even research bases, especially the United States, Germany and the United Kingdom, tend to support a response across a wider range of COVID-19 topics. Other G20 nations with less even research bases tend toward a more specialized response. However, one notable exception is Brazil, where a less diverse research base has responded strongly to COVID-19, reflecting the relevant strengths in its research portfolio, particularly around biosciences.

Jonathan Adams, Director at the Institute for Scientific Information at Clarivate and a co-author of this annual report said: "The G20 meeting is a crucial forum for international co-operation and it's increasingly important to understand how the world's leading economies are using their expertise and resources to address the world's present and future challenges. The overall pattern in COVID-19 research that we see from our analysis is clear: as in economics, diversity in national portfolios enables a rapid and agile response. These scorecards will help policymakers, observers and reporters to understand the strengths and opportunities of G20 member nations during this global crisis and beyond."

The national research profiles within the report are selective, highlighting chosen topics of current policy interest that identify good signals of the health of the research base for each G20 member nation. Key factors that contribute to impactful research are laid out for each nation in the report and benchmarked.

Some key findings include:

  • In Australia output has doubled in a decade and continues to rise, driven by exceptional international collaboration.
  • Brazil's output is rising both domestically and for international collaboration. Open access output is very strong across most disciplines – especially for international papers.
  • Mainland China boasts an enormous research workforce and a large volume of investment (more than two million researchers, Gross Expenditure on R&D [GERD] over 2% of GDP). The domestic research base is diversifying and growing in all areas with an expanding focus on social sciences on top of its solid technology base.
  • In Germany, investment is higher than EU neighbors, with GERD over 3% of GDP, while output per researcher is around G20 average. The citation impact of the research is relatively good, especially in life sciences, and it has a 14% share of the world's top 10% of papers.
  • In Italy, productivity per GERD is well above G20 average. Citation impact is good in all areas and the impact of domestic research is rising, while average performance is further boosted by international collaboration, which accounts for 55% of total output.
  • Research investment in Mexico is low and continues to fall (GERD/GDP is 0.28%), but rising output is boosted by high and rising productivity. Citation impact is now slowing including international collaboration.
  • Productivity in South Africa is high and output has been rising. There are consistently high levels of publication via open access across disciplines and the country has the second highest proportion of female researchers (45%).
  • In South Korea, a large workforce and the highest G20 GERD/GDP (4.6%) translate into strong academic output in engineering, reflecting excellent private sector funding and activity. Levels of publication via open access models are rising in all areas.
  • For the United Kingdom, the share of papers in the global top 10% (16.2% and rising) is the highest in the G20. International collaboration is exceptionally high, and rising, for such a large economy. The proportion of female researchers (39%) is above G20 average.
  • In the United States, although investment is rising, output has plateaued, and output/researcher has fallen below the G20 average.

Joel Haspel, SVP Strategy, Science at Clarivate said: "The world's strongest economies are clear drivers of research and innovation, which underpin the progress of society. The Institute for Scientific Information is uniquely placed to analyze and report on the comparative health of each G20 nation's research portfolio, setting Web of Science data alongside other key metrics on people, finance and patenting to help us more deeply understand their role in addressing the many challenges our world faces – from the pandemic to climate change to gender equality. By contributing to the conversation around G20 performance, Clarivate data is continuing to accelerate innovation and help to solve the world's most pressing problems."

Notes to editors:
Report authors are available for interview. 

The G20 is a group of 19 leading economies, with the EU as the additional 20th member. Collectively the 19 countries of the G20 represent two-thirds of the world's population, produce 80% of global GDP, spend 93% of global R&D, employ 89% of the world's researchers and publish 83% of the global research papers indexed in the Web of Science with more than five million articles and reviews indexed for the last three years.

See a full list of Global Research Reports from the Institute for Scientific Information: https://clarivate.com/webofsciencegroup/solutions/isi-reports/ 

About Clarivate
Clarivate™ is a global leader in providing solutions to accelerate the lifecycle of innovation. Our bold mission is to help customers solve some of the world's most complex problems by providing actionable information and insights that reduce the time from new ideas to life-changing inventions in the areas of science and intellectual property. We help customers discover, protect and commercialize their inventions using our trusted subscription and technology-based solutions coupled with deep domain expertise. For more information, please visit clarivate.com.

Media Contact
Rebecca Krahenbuhl, External Communications Manager, Science
media.enquiries@clarivate.com 

Cision
View original content to download multimedia:https://www.prnewswire.com/news-releases/clarivate-measures-research-performance-of-the-worlds-leading-economies-in-annual-g20-scorecard-report-301402275.html

SOURCE Clarivate Plc

© Canada Newswire, source Canada Newswire English

All news about CLARIVATE PLC
03:52aCLARIVATE : and the Chinese Academy of Sciences Release Annual Joint Report to Identify 17..
PU
12/07New Clarivate Report Reveals Luxury Brands are Accelerating Digital Transformation to M..
AQ
12/07Clarivate Report Finds Telehealth Can Close Gaps in Care and Ease Disparities
AQ
12/02Clarivate Stock Surges After Reaffirming 2021, 2022 Guidance, Closing of ProQuest Aquis..
MT
12/02Morgan Stanley Adjusts Price Target on Clarivate to $28 From $27, Maintains Overweight ..
MT
12/01Clarivate Completes Acquisition of ProQuest from Cambridge Information Group, Other Inv..
MT
12/01Dana Names Timothy Kraus as Chief Financial Officer
MT
12/01CLARIVATE : Successfully Completes Acquisition of ProQuest
PU
12/01CLARIVATE : Successfully Completes Acquisition of ProQuest - Form 8-K
PU
12/01CLARIVATE : Announces Change in Executive Leadership - Form 8-K
PU
More news
Analyst Recommendations on CLARIVATE PLC
More recommendations
Financials (USD)
Sales 2021 1 820 M - -
Net income 2021 -116 M - -
Net Debt 2021 6 613 M - -
P/E ratio 2021 -145x
Yield 2021 -
Capitalization 17 119 M 17 119 M -
EV / Sales 2021 13,0x
EV / Sales 2022 8,23x
Nbr of Employees 8 568
Free-Float 77,2%
Chart CLARIVATE PLC
Duration : Period :
Clarivate Plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CLARIVATE PLC
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 7
Last Close Price 24,93 $
Average target price 30,00 $
Spread / Average Target 20,3%
EPS Revisions
Managers and Directors
Jerre Lee Stead Executive Chairman & Chief Executive Officer
Richard Hanks Chief Financial Officer & Executive Vice President
Stefano Maestri Chief Technology Officer
Kerri Nelson Chief Operating Officer
Anthony Munk Lead Independent Director
Sector and Competitors
1st jan.Capi. (M$)
CLARIVATE PLC-16.09%17 057
WNS (HOLDINGS) LIMITED19.43%4 195
JMDC INC.42.64%3 971
VERRA MOBILITY CORPORATION15.13%2 411
SHANGHAI ATHUB CO.,LTD.-18.34%1 699
UMANIS S.A.64.80%293